MI TB Intensive
University of Medicine & Dentistry of New Jersey (UMDNJ), New Jersey Medical School Global Tuberculosis Institute, UMDNJ-CCOE, Michigan Department of Community Health,Ohio Department of Health, Indiana State Department of Health
Thursday, October 4, 2012 at 8:30 AM - Friday, October 5, 2012 at 2:30 PM (EDT)
TB Intensive Workshop
October 4-5, 2012
CNE/CME Certified Activity
Lexington Lansing Hotel
925 S.Creyts Road
Lansing, MI 48917
Jointly Sponsored By
University of Medicine & Dentistry of New Jersey (UMDNJ), New Jersey Medical School Global Tuberculosis Institute, UMDNJ-Center for Continuing and Outreach Education, Michigan Department of Community Health,Ohio Department of Health, Indiana State Department of Health
This activity is supported in part by an educational grant from the Centers for Disease Control and Prevention, Division of Tuberculosis Elimination
This intensive two - day workshop covers topics in management and treatment of tuberculosis including epidemiology, transmission & pathogenesis, diagnosis and treatment of TB, TB in children and adolescents, multi-drug resistant tuberculosis, TB/HIV co-infection, and key aspects of patient management. The format includes lectures, discussions, and case studies.
This workshop is designed for physicians, nurses and healthcare professionals, who are involved in the management of patients with TB, supervise those who provide care for TB patients, or are TB control staff responsible for program management. In addition to health department staff, individuals who work in the following settings would benefit from attending this workshop:
- Hospital Infection Control
- College or University Health
- Correctional Facilities
- Long Term Care Facilities
- Immigrant & Refugee Health
- Community Healthcare Providers
As the incidence of tuberculosis continues to decline, maintaining clinical and public health expertise in TB is particularly challenging. Therefore, ongoing training and education are important to develop and enhance skills in the diagnosis of TB, knowledge of recommended treatment guidelines, and the ability to interact effectively with public health agencies. This type of training is also important for new healthcare providers working in TB control or other settings.
Upon completion of this workshop, participants will be able to:
- Apply current advances for assessing risk, testing and treating latent TB infection to prevent development of disease
- Apply recommendations for the diagnosis and treatment of TB disease to prevent transmission and development of primary drug resistance
- Identify appropriate TB infection control measures along the continuum of care to prevent transmission and future cases of TB
- Describe approaches for managing adverse drug effects to anti-TB medications to minimize toxicity
- Explain how primary care providers and community agencies can collaborate to prevent missed opportunities in the diagnosis and treatment of TB
- Discuss strategies for managing TB in special patient populations e.g., immigrants and refugees, persons with mental illness and substance abuse issues, and homeless persons
- Develop individualized strategies to promote adherence in patients taking TB medications
In order to meet the learning objectives and receive continuing education credits, participants are required to attend the entire course, and complete an evaluation form at the end of the course. If you are unable to complete the entire course, you may not receive a certificate of completion but you will receive credit commensurate with your actual participation.
A post-course follow up evaluation will be done within 2 months of the course.
Thursday, October 4, 2012
8:30 am Registration & Sign-in
9:00 am Welcome & Course Overview
9:30 am Targeted Testing & Risk Assessment – Shu-Hua Wang, MD
10:00 am Medical Evaluation & CXR Interpretation – Paul Christensen, MD
10:45 am Break
11:00 am LTBI Treatment: Focus on New LTBI Regimen – Daniel Nafziger, MD
12:00 pm Lunch
1:00 pm Inpatient Standards of Care & Discharge Planning – Dana Kissner, MD
1:45 pm Importance of Laboratory & Clinical Monitoring -
James Sunstrum, MD & Angie Schooley, BS
2:45 pm Break
3:00 pm Managing Adverse Drug Reactions – Dean Van Loo, Pharm.D
3:45 pm Review
4:00 pm Adjourn
Friday, October 5, 2012
8:00 am Sign-In
8:30 am Expanded Role of Federally Qualified Health Centers -
Edward Zuroweste, MD
9:15 am Networking with Public Health & Clinical Practice -
Mazharullah Shaik, MD, Kim Sibilsky
10:15 am Break
10:30 am Immigration & Refugee Health – Maureen Murphy-Weiss, RN
11:15 am Challenges of Special Circumstances: Substance Abuse, Homelessness, & Mental Health Issues -
Sarah Burkholder, RN, MPH, Monica Heltz, RN, MPH
12:00 pm Lunch
12:45 pm Case Studies – Dana Kissner, MD, Shu-Hua Wang, MD
1:30 pm Partnerships in Action – Denise Bryan, MPA, Pamela Hackert, MD
2:15 pm Closing Remarks, Evaluation
2:30 pm Adjourn
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of UMDNJ-Center for Continuing and Outreach Education and UMDNJ-NJMS Global Tuberculosis Institute, Michigan Department of Community Health, Ohio Department of Health, and the Indiana State Department of Health. UMDNJ–Center for Continuing and Outreach Education is accredited by the ACCME to provide continuing medical education for physicians.
UMDNJ–Center for Continuing and Outreach Education designates this live activity for a maximum of 10.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
UMDNJ-Center for Continuing and Outreach Education is an approved provider of continuing nursing education by NJSNA, an accredited approver by the American Nurses Credentialing Center's COA. Provider number P173-11/09-12. Provider approval is valid through November 30, 2012.
This activity is awarded 10.5 contact hours (60 minute CH).
Provider approved by the California Board of Registered Nursing, Provider Number CEP 13780.
Nurses should only claim those contact hours actually spent participating in this activity.
It is the policy of the UMDNJ – Center for Continuing and Outreach Education that all speakers and planners disclose any real or apparent conflicts of interest related to the content of this educational activity and also disclose discussions of off-label or investigational uses of drugs or devices during their presentation(s). These disclosures will be made in the activity handouts.
Please apply online by September 14, 2012 using the following link to Eventbrite:
Notification of acceptance and additional course information will be sent via email.
The registration fee is $75 and payment must be received prior to the course. Acceptable forms of payment are purchase order or check or money order made payable to NJMS Global Tuberculosis Institute.
Applicants from Indiana, Michigan, and Ohio should contact their state TB Program to obtain additional information.
Sarah Burkholder, RN, MPH
Patricia Raines, RN, MSN
Maureen Murphy-Weiss, RN
UMDNJ reserves the right to modify the activity content, faculty and activities, and reserves the right to cancel this activity,